FEVR (Inspire Faithward Large Cap Momentum ESG ETF) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

See exactly how FEVR's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for FEVR and 80,000+ other tickers.
This actively managed exchange-traded fund (ETF) primarily invests in large-capitalization equities. It commits at least 80% of its net assets, along with any borrowed funds, to companies with a market valuation of $13 billion or more. Furthermore, these investments must align with the fund's established environmental, social, and governance (ESG) criteria.

Fevertree Drinks (AIM:FEVR) has retained the backing of Jefferies, which kept its 'buy' recommendation and 1,100p price target after first-half results pointed to stronger US momentum and improving earnings prospects. The broker viewed the results as early evidence that of the Group's partnership with Molson Coors is beginning to deliver, with US revenue growth reaching 11% at constant currency and sales momentum building as distribution, merchandising and marketing activity expands.

Fevertree Drinks (AIM: FEVR) delivered stronger first-half earnings as US sales accelerated under its Molson Coors partnership and the UK business returned to growth. Adjusted Fever-Tree brand revenue increased 8% at constant currency to £183.6 million in the six months to 30 June, while adjusted EBITDA rose 9% to £20.1 million.

Fevertree Drinks (AIM:FEVR), the premium mixer brand, posted a 2% rise in full-year revenue to £375 million but saw profits slide due to initial costs from the first year of its US distribution partnership with Molson Coors and a new environmental levy. Adjusted EBITDA fell 16% to £42.4 million, as margins fell from 13.7% to 11.3%.

There was a fresh burst of life in Fevertree Drinks (AIM:FEVR) share price after Jefferies upgraded the premium mixer maker to 'buy' from 'hold', sending the shares up 4.5% to 822p. The investment bank also raised its target price to £11, implying more than 35% upside, arguing that the company's new partnership in the United States with Molson Coors marks a “transformational” moment.

Fevertree Drinks (AIM:FEVR) reported interim results in line with expectations and said it remained confident in the full-year outlook. Revenue was stable at £172.2 million, up 2% at constant currency.